Pfizer is urging the Albanese Government to use the 2026–27 Budget to reverse what it describes as chronic underinvestment in the PBS, warning that Australia is falling behind comparable countries on access to innovative medicines and vaccines and squandering large productivity gains in the process. …
Pfizer calls for Budget shift, citing missed medicines and the impact of lost productivity
February 1, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
PYC to present early polycystic kidney disease trial data at US nephrology conference
October 7, 2026 - - Australian Biotech -
CSL raises US$1.5 billion from US bond investors to refinance debt
October 7, 2026 - - Latest News -
Every serious attempt to reform PBS pricing has run into the same problem
October 7, 2026 - - Latest News -
AFT reaffirms profit guidance as its R&D pipeline moves toward 2029 launches
October 7, 2026 - - Latest News -
The patient who knows what they want is informed and not a danger
October 7, 2026 - - Latest News -
TGA turns to national security surveillance platform to police therapeutic goods compliance
October 6, 2026 - - Latest News -
Company size shapes CEO pay trends in Australian health care and biotechnology
October 6, 2026 - - Latest News